Heat Biologics (HTBX) Files Amended Securities Prospectus Supplement

December 1, 2016 6:25 AM EST
Get Alerts HTBX Hot Sheet
Trade HTBX Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Heat Biologics (Nasdaq: HTBX) filed an amended prospectus with the U.S. SEC to sell up to 9,100,000 Shares of Common Stock and Warrants to Purchase Up to 6,825,000 Shares of Common Stock

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Equity Offerings

Add Your Comment